Skip to main content
Clinical Trials/NCT04837573
NCT04837573
Completed
Not Applicable

Evaluating the Feasibility and Acceptability of a Therapeutically-Grounded Virtual Sister Circle Intervention for Black Women With Depressive Symptoms

Kia Skrine Jeffers, PhD, RN, PHN1 site in 1 country30 target enrollmentSeptember 14, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depressive Symptoms
Sponsor
Kia Skrine Jeffers, PhD, RN, PHN
Enrollment
30
Locations
1
Primary Endpoint
Assess Acceptability according to the Theoretical Framework of Acceptability
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the feasibility and acceptability of a protocol for middle- and older-aged Black women with depressive symptoms.

Registry
clinicaltrials.gov
Start Date
September 14, 2022
End Date
April 2, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Kia Skrine Jeffers, PhD, RN, PHN
Responsible Party
Sponsor Investigator
Principal Investigator

Kia Skrine Jeffers, PhD, RN, PHN

Assistant Professor

University of California, Los Angeles

Eligibility Criteria

Inclusion Criteria

  • Identify as Black or African American
  • Identify as female
  • Age 40 years and older
  • Community-dwelling
  • Self-report of experiencing depressive symptoms
  • Ability to commit to the 8-week intervention
  • Access to Zoom
  • Speak and read English

Exclusion Criteria

  • Have a diagnosis of bipolar, but is not taking medication for the condition
  • Experiencing psychosis

Outcomes

Primary Outcomes

Assess Acceptability according to the Theoretical Framework of Acceptability

Time Frame: 16 weeks

Qualitative assessment of Acceptability. The interview guide will be organized according to the constructs of the Theoretical Framework of Acceptability. Methodological conventions of qualitative description will be used to analyze the data.

Recruitment, completion, and retention rates of participants

Time Frame: 16 weeks

80 percent recruitment, 80 percent completion, and 75 percent retention

Secondary Outcomes

  • Changes in Acceptance and Action Questionnaire II (AAQ-II) from baseline at 8 weeks and 16 weeks(baseline, 8 weeks, 16 weeks)
  • Changes in Positive and Negative Affect Schedule (PANAS) Scale from baseline at 8 weeks and 16 weeks(baseline, 8 weeks, 16 weeks)
  • Changes in Perceived Stress Scale (PSS) from baseline at 8 weeks and 16 weeks(baseline, 8 weeks, 16 weeks)

Study Sites (1)

Loading locations...

Similar Trials